Abivax S.a.

This study tested whether a new daily pill called ABX464 could help control moderate-to-severe ulcerative colitis. It involved 355 adults whose disease did not respond well to standard medications. Participants took one of three doses of the pill or a placebo daily for 16 weeks t…

This study tested whether taking ABX464 daily could help people with moderate to severe ulcerative colitis maintain their improvement over a long period. It involved 217 patients who had already completed an initial treatment study and wanted to continue. Participants took the me…

This study tested whether a daily pill called ABX464 could help people with moderate to severe ulcerative colitis who haven't responded well to other treatments. Researchers compared the pill against a placebo in 639 participants over 8 weeks to see if it could reduce symptoms an…

This study tested whether a daily pill called ABX464 could help control moderate-to-severe ulcerative colitis in people who haven't gotten enough relief from standard treatments. Researchers compared the pill to a placebo (inactive pill) in 636 participants over 8 weeks to see if…

This study followed 40 patients with moderate to severe rheumatoid arthritis for up to two years to see if the oral medication ABX464 remains safe and effective over time. All participants received the same daily dose of the drug, regardless of whether they received the real medi…